Literature DB >> 26456599

Compendium of FAM46C gene mutations in plasma cell dyscrasias.

Marzia Barbieri1, Martina Manzoni2, Sonia Fabris1, Gabriella Ciceri2, Katia Todoerti3, Vittorio Simeon3, Pellegrino Musto3, Agostino Cortelezzi1,2, Luca Baldini1,2, Antonino Neri4,5, Marta Lionetti6.   

Abstract

Entities:  

Keywords:  FAM46C; multiple myeloma; mutational analysis; next-generation sequencing; plasma cell leukaemia

Mesh：

Substances：

Year:  2015        PMID： 26456599     DOI： 10.1111/bjh.13793

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  20 in total

1.  Loss of FAM46C Promotes Cell Survival in Myeloma.

Authors:  Yuan Xiao Zhu; Chang-Xin Shi; Laura A Bruins; Patrick Jedlowski; Xuewei Wang; K Martin Kortüm; Moulun Luo; Jonathan M Ahmann; Esteban Braggio; A Keith Stewart
Journal:  Cancer Res       Date:  2017-06-15       Impact factor: 12.701

Review 2.  Evolutionary biology of high-risk multiple myeloma.

Authors:  Charlotte Pawlyn; Gareth J Morgan
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

3.  Structural and Functional Analyses of the FAM46C/Plk4 Complex.

Authors:  Hua Chen; Defen Lu; Guijun Shang; Guoming Gao; Xuewu Zhang
Journal:  Structure       Date:  2020-05-19       Impact factor: 5.006

4.  Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.

Authors:  Xu-Ying Wan; Xiao-Feng Zhai; Yi-Ping Jiang; Ting Han; Qiao-Yan Zhang; Hai-Liang Xin
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

5.  Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature.

Authors:  Marta Lionetti; Marzia Barbieri; Martina Manzoni; Sonia Fabris; Cecilia Bandini; Katia Todoerti; Filomena Nozza; Davide Rossi; Pellegrino Musto; Luca Baldini; Antonino Neri
Journal:  Oncotarget       Date:  2016-04-19

6.  The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma.

Authors:  Seweryn Mroczek; Justyna Chlebowska; Tomasz M Kuliński; Olga Gewartowska; Jakub Gruchota; Dominik Cysewski; Vladyslava Liudkovska; Ewa Borsuk; Dominika Nowis; Andrzej Dziembowski
Journal:  Nat Commun       Date:  2017-09-20       Impact factor: 14.919

7.  FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.

Authors:  Qiao-Yan Zhang; Xiao-Qiang Yue; Yi-Ping Jiang; Ting Han; Hai-Liang Xin
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

8.  A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma.

Authors:  Domenica Ronchetti; Luca Agnelli; Alessandro Pietrelli; Katia Todoerti; Martina Manzoni; Elisa Taiana; Antonino Neri
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

9.  FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases.

Authors:  Krzysztof Kuchta; Anna Muszewska; Lukasz Knizewski; Kamil Steczkiewicz; Lucjan S Wyrwicz; Krzysztof Pawlowski; Leszek Rychlewski; Krzysztof Ginalski
Journal:  Nucleic Acids Res       Date:  2016-04-07       Impact factor: 16.971

10.  Integrated multigene expression panel to prognosticate patients with gastric cancer.

Authors:  Mitsuro Kanda; Kenta Murotani; Haruyoshi Tanaka; Takashi Miwa; Shinichi Umeda; Chie Tanaka; Daisuke Kobayashi; Masamichi Hayashi; Norifumi Hattori; Masaya Suenaga; Suguru Yamada; Goro Nakayama; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Oncotarget       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.